JP2021536472A5 - - Google Patents

Info

Publication number
JP2021536472A5
JP2021536472A5 JP2021512682A JP2021512682A JP2021536472A5 JP 2021536472 A5 JP2021536472 A5 JP 2021536472A5 JP 2021512682 A JP2021512682 A JP 2021512682A JP 2021512682 A JP2021512682 A JP 2021512682A JP 2021536472 A5 JP2021536472 A5 JP 2021536472A5
Authority
JP
Japan
Prior art keywords
composition according
compound
formula
dithiol
cyclodextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512682A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021536472A (ja
JP7362725B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/073873 external-priority patent/WO2020049166A1/en
Publication of JP2021536472A publication Critical patent/JP2021536472A/ja
Publication of JP2021536472A5 publication Critical patent/JP2021536472A5/ja
Application granted granted Critical
Publication of JP7362725B2 publication Critical patent/JP7362725B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021512682A 2018-09-06 2019-09-06 アネトールトリチオンおよびその誘導体のシクロデキストリン複合体を含む医薬組成物 Active JP7362725B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862727691P 2018-09-06 2018-09-06
US62/727,691 2018-09-06
EP18306172 2018-09-06
EP18306172.0 2018-09-06
PCT/EP2019/073873 WO2020049166A1 (en) 2018-09-06 2019-09-06 Pharmaceutical composition comprising cyclodextrin compexes of anethole trithione or derivatives thereof

Publications (3)

Publication Number Publication Date
JP2021536472A JP2021536472A (ja) 2021-12-27
JP2021536472A5 true JP2021536472A5 (enExample) 2022-09-15
JP7362725B2 JP7362725B2 (ja) 2023-10-17

Family

ID=67841092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021512682A Active JP7362725B2 (ja) 2018-09-06 2019-09-06 アネトールトリチオンおよびその誘導体のシクロデキストリン複合体を含む医薬組成物

Country Status (11)

Country Link
US (1) US12295969B2 (enExample)
EP (1) EP3846856A1 (enExample)
JP (1) JP7362725B2 (enExample)
KR (1) KR20210054540A (enExample)
CN (1) CN113038969A (enExample)
AU (2) AU2019336943A1 (enExample)
BR (1) BR112021003997A2 (enExample)
CA (1) CA3111886A1 (enExample)
IL (1) IL281161B2 (enExample)
MX (1) MX2021002611A (enExample)
WO (1) WO2020049166A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240050402A1 (en) * 2020-12-10 2024-02-15 Frédéric MARIN Anethole trithione administration regimen for the prevention or treatment of ischemia-reperfusion injuries
EP4112051A1 (en) 2021-06-30 2023-01-04 Op2 Drugs Anethole trithione for the treatment of vasculitides
CN114558004B (zh) * 2022-03-29 2023-08-11 奎马特里克斯有限公司 Qtx125药物制剂
CN115738757B (zh) * 2022-11-24 2024-03-29 中国海洋大学 一种基于磺丁基-β-环糊精离子传输通道的单价阳离子选择性分离膜及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262165A (en) 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
PL181582B1 (pl) 1995-06-07 2001-08-31 Ortho Mcneil Pharm Inc Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
WO1998027970A2 (en) * 1996-12-24 1998-07-02 National Research Council Of Canada Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
CN1771938A (zh) 2004-11-09 2006-05-17 胡才忠 茴三硫脂质体及其制备方法
CA2997855A1 (en) * 2015-09-08 2017-03-16 Philippe DIOLEZ Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ros) production
BR112018004518A2 (pt) * 2015-09-08 2019-03-19 OP2 Drugs compostos para o tratamento de doenças ligadas à produção de espécies reativas de oxigênio (ros) mitocondriais
CA3055122A1 (en) * 2017-03-07 2018-09-13 OP2 Drugs Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ros) production

Similar Documents

Publication Publication Date Title
TWI765451B (zh) 作為erk抑制劑的螺環類化合物及其應用
CN101142198B (zh) 用于治疗疾病的异*唑坎布雷它斯丁衍生物
JP2019518050A5 (enExample)
JP2019510787A5 (enExample)
CA2494049A1 (en) Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
WO2021017880A1 (zh) 一类靶向stat3双功能磷酸化位点的三芳香环类化合物及其应用
RU2010145529A (ru) Композиции гидрофобных производных таксана и их применение
JP2018511647A5 (enExample)
JP2007504284A5 (enExample)
JP2005526836A5 (enExample)
JP2005535731A5 (enExample)
TWI415613B (zh) Anti-cancer agent resistance to overcome the agent
KR20110013411A (ko) (f-19)-표지된 l-글루탐산 및 l-글루타민 유도체 (ⅲ), 그의 용도 및 그의 수득 방법
JP2022544538A5 (enExample)
JP2024530956A5 (enExample)
JP2023526490A (ja) フルオロピロロピリジン系化合物及びその使用
JP2024538730A5 (enExample)
WO2023038088A1 (ja) トリスルフィド化合物を用いる、肝細胞増殖因子中のチロシン残基のニトロ化を防止する方法
CN115397846A (zh) 疏水性修饰的白蛋白及其制备方法和用途
KR101536488B1 (ko) 이미다졸 유도체, 그의 제조 방법 및 용도
CN111372939A (zh) 反式-[四氯双(1h-吲唑)钌(iii)]及其组合物的制备
CN106798731B (zh) 一种氟苯尼考可溶性粉的制备方法
JP2006506389A5 (enExample)
CN103183722B (zh) 一种乙二醛酶i抑制剂及其制备方法和医药用途
JP2004224802A (ja) 抗菌剤